Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar
Background: Infectious endocarditis (ie) is a serious and potentially fatal illness. Epidemiology, treatment options and results have changed considerably over the past two decades. The objective of the study was to describe epidemiology, clinical features and results of Qatar IE patients.
Methods: Patients were identified in the Hamad Medical Corporation Corporation’s electronic archives, the National Reference Center for Qatar State. We included 18-year-olds with a DUC diagnosis of DUC in the period from January 2015 to September 2017. Demographic and clinical data were recovered. Descriptive statistics were performed and a logistic regression analysis was used to describe the relationship between patient characteristics and hospital mortality. All potentially relevant variables have been included in the univariate analysis, while those with P <0,1 in the UNIVARIARY logistics regression model have been included in multivariate analysis. For the final template, we calculated dimension ratios (or) adjusted for each of the included variables, as well as their 95% confidence intervals (95% CI). The data was analyzed using Stata Software Version 15 (Statacorp, College Station, Texas, United States). The study was approved by the Council for Institutional Research with a renunciation of informed consent.
Results: Fifty-seven cases have been included, 70% of whom were men. The average age was 51 (± 16.8 years). Eleven (19%) were associated with prosthetic valves and 6 (11%) with implantable cardiac devices. Fever (84%), dyspnea (46%) and heart failure (37%) were the most common presentations. Only 58% of patients had pre-existing valvular heart disease or intracardiac. Cutaneous infections (10 patients, 18%) were the most common infection portals, followed by venous catheters, recent valve surgery and implantable heart devices. Staphylococci were involved in 19 (34%) and streptococcaceae in 9 patients (16%), while 21 patients (37%) were negative of culture. The target left (49 patients, 86%) was predominant.
Educational learning: mutual exchange between high school students and graduate students in the field of microbiology
The pedagogical learning process becomes more attractive when practical classes are used as part of methodological tools. Aim (i) stimulate the interest of high school students in the microbiological world and (ii) provide a didactic experience for graduate microbiology students, practical courses have been undertaken. These courses were conducted in the years 2016 and 2017, using the infrastructure held in Federal Viçosa Univeridade.
In short, laboratory classes have been prepared and taught by graduate microbiology students and an evaluation questionnaire has been answered by participants after classes. About 95% of high school students, two years, have evaluated the experience outside of the school routine as very good and good. A total of 90.09% (2016) and 100% (2017) graduate students evaluated this experience as good and good. The relationship between high school students and graduate students has also increased the curiosity of the first on the university environment.
As a result, the retention of information concerning the “world of microbiology” has been verified after one year and the students were able to remember the important terms related to the microbiology class. In addition, this work has allowed students graduate students and high school students to create a closer relationship and create an excellent pedagogical learning strategy for both.
Tackling the pollution of real environmental paper: a microbiology lesson based on problems on carbon assimilation
Government and educational organizations advocate for the adoption of student-centered educational strategies in the Undergraduate programs. These strategies are known to benefit students by increasing performance and improving the control of the content of the class and increasing the content of the class and increasing the effect, particularly in students of racial / ethnic minorities underrepresented . Among these strategies, the case study and project-based learning allow students to master courses while collectively addressing relevant and real society issues. In particular, environmental pollution with paper-based products offers a microbiology problem on which microbiology students discover the role of microorganisms in paper waste management as well as microbiological and biochemical processes involved in the Secretion of proteins, the absorption of nutrients and energy metabolism.
Delivered in a hybrid class returned to an active learning laboratory (TEAL) activated by the technology, this lesson taught students about the secretion of exoenzyme, the hydrolysis of biopolymers, the intracellular transport of sugars and the catabolic reactions of sugar. Students have demonstrated an increased understanding of exoenzyme function and secretion, as well as how cells reach exoenzyme hydrolysis products. However, students had difficulty placing exoenzyme products transported in metabolic processes. Our results show increased perceived knowledge of students as well as understanding societal implications for these microbiological concepts. Our deviated lesson from knowledge silos in which students learn information in discrete topics.
Cefuroxime sodium salt |
|||
GA1625-5G | Glentham Life Sciences | 5 g | EUR 288 |
Oleic acid, For biochemistry |
|||
RM5371-5ML | EWC Diagnostics | 1 unit | EUR 50.98 |
Description: Oleic acid, For biochemistry |
Amino acid-kit ?(for biochemistry) |
|||
K007-1KT | EWC Diagnostics | 1 unit | EUR 67.59 |
Description: Amino acid-kit ?(for biochemistry) |
Amino acid-kit ?(for biochemistry) |
|||
K007-5KT | EWC Diagnostics | 1 unit | EUR 303.95 |
Description: Amino acid-kit ?(for biochemistry) |
Cefuroxime Sodium |
|||
317455 | MedKoo Biosciences | 100.0mg | EUR 120 |
Cefuroxime Sodium |
|||
C023-1G | TOKU-E | 1 g | EUR 77.89 |
Description: C16H15N4N/AO8S |
Cefuroxime Sodium |
|||
C023-5G | TOKU-E | 5 g | EUR 258.61 |
Description: C16H15N4N/AO8S |
Cefuroxime (sodium) |
|||
HY-B1256 | MedChemExpress | 1g | EUR 192 |
Cefuroxime sodium |
|||
T1224-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Cefuroxime sodium |
Cefuroxime sodium |
|||
T1224-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Cefuroxime sodium |
Cefuroxime sodium |
|||
T1224-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Cefuroxime sodium |
Cefuroxime sodium |
|||
T1224-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Cefuroxime sodium |
Cefuroxime sodium |
|||
T1224-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Cefuroxime sodium |
Cefuroxime |
|||
C248088 | Toronto Research Chemicals | 100mg | EUR 487 |
Description: 55268-75-2 |
Cefuroxime |
|||
GA9610-1 | Glentham Life Sciences | 1 | EUR 125.1 |
Cefuroxime |
|||
GA9610-100 | Glentham Life Sciences | 100 | EUR 39.4 |
Cefuroxime |
|||
GA9610-100MG | Glentham Life Sciences | 100 mg | EUR 84 |
Cefuroxime |
|||
GA9610-1G | Glentham Life Sciences | 1 g | EUR 187.2 |
Cefuroxime |
|||
GA9610-250 | Glentham Life Sciences | 250 | EUR 63.3 |
Cefuroxime |
|||
GA9610-250MG | Glentham Life Sciences | 250 mg | EUR 112.8 |
Cefuroxime-d3 |
|||
C248052 | Toronto Research Chemicals | 10mg | EUR 293 |
Cefuroxime axetil |
|||
584893 | MedKoo Biosciences | 350.0mg | EUR 535 |
Cefuroxime Axetil |
|||
C248065 | Toronto Research Chemicals | 100mg | EUR 227 |
Description: 64544-07-6 |
Cefuroxime axetil |
|||
C6478-25 | ApexBio | 25mg | EUR 45 |
Cefuroxime axetil |
|||
T1227-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Cefuroxime axetil |
Cefuroxime axetil |
|||
T1227-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Cefuroxime axetil |
Cefuroxime axetil |
|||
T1227-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Cefuroxime axetil |
Cefuroxime axetil |
|||
T1227-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Cefuroxime axetil |
Cefuroxime axetil |
|||
T1227-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Cefuroxime axetil |
Cefuroxime (free base) |
|||
412546 | MedKoo Biosciences | 100.0mg | EUR 418 |
Cefuroxime free acid |
|||
C282-1G | TOKU-E | 1 g | EUR 79.57 |
Description: C16H16N4O8S |
Cefuroxime free acid |
|||
C282-5G | TOKU-E | 5 g | EUR 264.35 |
Description: C16H16N4O8S |
Descarbamoyl Cefuroxime |
|||
D288830 | Toronto Research Chemicals | 10mg | EUR 198 |
Description: 56271-94-4 |
Descarbamoyl cefuroxime |
|||
T11000-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Descarbamoyl cefuroxime |
Descarbamoyl cefuroxime |
|||
T11000-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Descarbamoyl cefuroxime |
Descarbamoyl cefuroxime |
|||
T11000-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Descarbamoyl cefuroxime |
Descarbamoyl cefuroxime |
|||
T11000-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Descarbamoyl cefuroxime |
Descarbamoyl cefuroxime |
|||
T11000-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Descarbamoyl cefuroxime |
Cefuroxime Axetil-d3 |
|||
C248067 | Toronto Research Chemicals | 25mg | EUR 11200 |
Cefuroxime CXM 30 mcg |
|||
SD061-1PK | EWC Diagnostics | 1 unit | EUR 6.31 |
Description: Cefuroxime CXM 30 mcg |
Cefuroxime CXM 30 mcg |
|||
SD061-1VL | EWC Diagnostics | 1 unit | EUR 2.99 |
Description: Cefuroxime CXM 30 mcg |
Cefuroxime CXM 30 mcg |
|||
SD061-5CT | EWC Diagnostics | 1 unit | EUR 6.65 |
Description: Cefuroxime CXM 30 mcg |
Cefuroxime CXM 30 mcg |
|||
SD061-5VL | EWC Diagnostics | 1 unit | EUR 11.84 |
Description: Cefuroxime CXM 30 mcg |
Cefuroxime CXM 30 mcg |
|||
SD061-5X50DS | EWC Diagnostics | 1 unit | EUR 6.5 |
Description: Cefuroxime CXM 30 mcg |
Di(cefuroxime Ethyl) Ether |
|||
D431300 | Toronto Research Chemicals | 5mg | EUR 800 |
Description: 1202925-10-7 |
(E)-Cefuroxime-d3 Axetil |
|||
C248077 | Toronto Research Chemicals | 100mg | EUR 17000 |
Descarbamoyl Cefuroxime-d3 |
|||
D288832 | Toronto Research Chemicals | 10mg | EUR 224 |
Δ2-Cefuroxime Methyl Ester |
|||
C248085 | Toronto Research Chemicals | 50mg | EUR 173 |
Cefuroxime Axetil Impurity C (85%) |
|||
C248080 | Toronto Research Chemicals | 10mg | EUR 775 |
Description: 76598-06-6 |
Cefuroxime Axetil (USP grade powder) |
|||
51R-U098220 | Fitzgerald | 350 mg | EUR 580 |
Description: Cefuroxime Axetil (USP grade powder) chemical reference substance |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-10ST | EWC Diagnostics | 1 unit | EUR 21.95 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-120ST | EWC Diagnostics | 1 unit | EUR 143.06 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-150ST | EWC Diagnostics | 1 unit | EUR 164.38 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-30ST | EWC Diagnostics | 1 unit | EUR 53.07 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-60ST | EWC Diagnostics | 1 unit | EUR 95.53 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Cefuroxime Ezy MIC Strip CXM (0.016-256m |
|||
EM102-90ST | EWC Diagnostics | 1 unit | EUR 124.27 |
Description: Cefuroxime Ezy MIC Strip CXM (0.016-256m |
Desacetyloxyethyl (E)-Cefuroxime Axetil |
|||
D289280 | Toronto Research Chemicals | 10mg | EUR 295 |
Description: 97232-97-8 |
5-Aminomethyl-2-carboxy Cefuroxime |
|||
C249000 | Toronto Research Chemicals | 25mg | EUR 9200 |
Delta2-Cefuroxime Axetil (Cefuroxime Axetil Delta-3 Isomer) |
|||
C248070 | Toronto Research Chemicals | 10mg | EUR 2325 |
Description: 123458-61-7 |
Cefuroxime Axetil d-3 iso (USP grade powder) |
|||
51R-U098231 | Fitzgerald | 10 mg | EUR 1761 |
Description: Cefuroxime Axetil d-3 iso (USP grade powder) chemical reference substance |
Cefuracetime (E-isomer) Sodium Salt |
|||
C243940 | Toronto Research Chemicals | 100mg | EUR 234 |
Description: 97170-20-2 |
Biochemical Test Kit for Salmonella |
|||
K141-10KT | EWC Diagnostics | 1 unit | EUR 25.63 |
Description: Biochemical Test Kit for Salmonella |
Biochemical Test Kit for Salmonella |
|||
K141-5KT | EWC Diagnostics | 1 unit | EUR 14.23 |
Description: Biochemical Test Kit for Salmonella |
HiMotility™ Biochemical Kit for Salmonel |
|||
KBM002-5KT | EWC Diagnostics | 1 unit | EUR 29.67 |
Description: HiMotility™ Biochemical Kit for Salmonel |
Biochemical Test Kit for Shigella |
|||
K140-10KT | EWC Diagnostics | 1 unit | EUR 130.52 |
Description: Biochemical Test Kit for Shigella |
Biochemical Test Kit for Shigella |
|||
K140-5KT | EWC Diagnostics | 1 unit | EUR 72.53 |
Description: Biochemical Test Kit for Shigella |
HiMotility™ Biochemical Kit for |
|||
KBM002-10KT | EWC Diagnostics | 1 unit | EUR 50.53 |
Description: HiMotility™ Biochemical Kit for |
HiMotility™ Biochemical Kit for |
|||
KBM002-20KT | EWC Diagnostics | 1 unit | EUR 72.14 |
Description: HiMotility™ Biochemical Kit for |
HiMotility™ Biochemical Kit for E.coli |
|||
KBM001-10KT | EWC Diagnostics | 1 unit | EUR 50.53 |
Description: HiMotility™ Biochemical Kit for E.coli |
HiMotility™ Biochemical Kit for E.coli |
|||
KBM001-20KT | EWC Diagnostics | 1 unit | EUR 72.14 |
Description: HiMotility™ Biochemical Kit for E.coli |
Biochemical Test Kit for Vibrio cholera |
|||
K138-10KT | EWC Diagnostics | 1 unit | EUR 94.6 |
Description: Biochemical Test Kit for Vibrio cholera |
Biochemical Test Kit for Vibrio cholera |
|||
K138-5KT | EWC Diagnostics | 1 unit | EUR 49.85 |
Description: Biochemical Test Kit for Vibrio cholera |
HiMotility™ Biochemical Kit for V. chol |
|||
KBM004-10KT | EWC Diagnostics | 1 unit | EUR 68.78 |
Description: HiMotility™ Biochemical Kit for V. chol |
HiMotility™ Biochemical Kit for V. chol |
|||
KBM004-20KT | EWC Diagnostics | 1 unit | EUR 98.33 |
Description: HiMotility™ Biochemical Kit for V. chol |
HiMotility™ Biochemical Kit for V. chol |
|||
KBM004-5KT | EWC Diagnostics | 1 unit | EUR 40.38 |
Description: HiMotility™ Biochemical Kit for V. chol |
Biochemical Test Kit for Vibrio parahaem |
|||
K139-10KT | EWC Diagnostics | 1 unit | EUR 94.92 |
Description: Biochemical Test Kit for Vibrio parahaem |
Biochemical Test Kit for Vibrio parahaem |
|||
K139-5KT | EWC Diagnostics | 1 unit | EUR 50 |
Description: Biochemical Test Kit for Vibrio parahaem |
HiMotility™ Biochemical Kit for V. parah |
|||
KBM005-10KT | EWC Diagnostics | 1 unit | EUR 68.78 |
Description: HiMotility™ Biochemical Kit for V. parah |
HiMotility™ Biochemical Kit for V. parah |
|||
KBM005-20KT | EWC Diagnostics | 1 unit | EUR 98.33 |
Description: HiMotility™ Biochemical Kit for V. parah |
HiMotility™ Biochemical Kit for V. parah |
|||
KBM005-5KT | EWC Diagnostics | 1 unit | EUR 40.38 |
Description: HiMotility™ Biochemical Kit for V. parah |
HiMotility™ Biochemical Kit for Listeria |
|||
KBM003A-10KT | EWC Diagnostics | 1 unit | EUR 50.53 |
Description: HiMotility™ Biochemical Kit for Listeria |
HiMotility™ Biochemical Kit for Listeria |
|||
KBM003A-20KT | EWC Diagnostics | 1 unit | EUR 72.14 |
Description: HiMotility™ Biochemical Kit for Listeria |
HiMotility™ Biochemical Kit for Listeria |
|||
KBM003A-5KT | EWC Diagnostics | 1 unit | EUR 29.67 |
Description: HiMotility™ Biochemical Kit for Listeria |
HiMotility™ Biochemical Kit for Shigella |
|||
KBM006-10KT | EWC Diagnostics | 1 unit | EUR 68.83 |
Description: HiMotility™ Biochemical Kit for Shigella |
HiMotility™ Biochemical Kit for Shigella |
|||
KBM006-20KT | EWC Diagnostics | 1 unit | EUR 98.33 |
Description: HiMotility™ Biochemical Kit for Shigella |
HiMotility™ Biochemical Kit for Shigella |
|||
KBM006-5KT | EWC Diagnostics | 1 unit | EUR 40.38 |
Description: HiMotility™ Biochemical Kit for Shigella |
Octyl sulphate, sodium salt, For HPLC |
|||
RM1734-1G | EWC Diagnostics | 1 unit | EUR 17.44 |
Description: Octyl sulphate, sodium salt, For HPLC |
Octyl sulphate, sodium salt, For HPLC |
|||
RM1734-5G | EWC Diagnostics | 1 unit | EUR 78.49 |
Description: Octyl sulphate, sodium salt, For HPLC |
Cefoxitin Sodium Salt |
|||
B1892-1G | Biovision | each | EUR 222 |
Cefoxitin Sodium Salt |
|||
B1892-500 | Biovision | each | EUR 157.2 |
Cefoxitin Sodium Salt |
|||
B1892-5G | Biovision | each | EUR 692.4 |
Cefazolin Sodium Salt |
|||
B1530-1G | Biovision | each | EUR 170.4 |
Cefazolin Sodium Salt |
|||
B1530-5G | Biovision | each | EUR 430.8 |
Cefoxitin Sodium Salt |
|||
C243200 | Toronto Research Chemicals | 1g | EUR 391 |
Description: 33564-30-6 |
Cefonicid (sodium salt) |
|||
C3812-1000 | ApexBio | 1 g | EUR 291 |
Description: second-generation cephalosporin antibiotic |
Cefonicid (sodium salt) |
|||
C3812-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 38 |
Description: second-generation cephalosporin antibiotic |
Cefonicid (sodium salt) |
|||
C3812-500 | ApexBio | 500 mg | EUR 164 |
Description: second-generation cephalosporin antibiotic |
Cefazolin (sodium salt) |
|||
C4183-1000 | ApexBio | 1 g | EUR 97 |
Description: broad-spectrum, first-generation cephalosporin antibiotic |
Cefazolin (sodium salt) |
|||
C4183-250 | ApexBio | 250 mg | EUR 43 |
Description: broad-spectrum, first-generation cephalosporin antibiotic |
Cefazolin (sodium salt) |
|||
C4183-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 38 |
Description: broad-spectrum, first-generation cephalosporin antibiotic |
Cefazolin (sodium salt) |
|||
C4183-500 | ApexBio | 500 mg | EUR 72 |
Description: broad-spectrum, first-generation cephalosporin antibiotic |
Cefazolin Sodium Salt |
|||
C242500 | Toronto Research Chemicals | 100mg | EUR 80 |
Description: 27164-46-1 |
Cefoxitin (sodium salt) |
|||
C4849-1000 | ApexBio | 1 g | EUR 116 |
Description: second generation cephalosporin antibiotic |
Cefoxitin (sodium salt) |
|||
C4849-250 | ApexBio | 250 mg | EUR 40 |
Description: second generation cephalosporin antibiotic |
Cefoxitin (sodium salt) |
|||
C4849-500 | ApexBio | 500 mg | EUR 70 |
Description: second generation cephalosporin antibiotic |
Cefoxitin sodium salt |
|||
GA4412-1 | Glentham Life Sciences | 1 | EUR 79.1 |
Cefoxitin sodium salt |
|||
GA4412-1G | Glentham Life Sciences | 1 g | EUR 132 |
Cefoxitin sodium salt |
|||
GA4412-250 | Glentham Life Sciences | 250 | EUR 31.7 |
Cefoxitin sodium salt |
|||
GA4412-250MG | Glentham Life Sciences | 250 mg | EUR 74.4 |
Cefoxitin sodium salt |
|||
GA4412-5 | Glentham Life Sciences | 5 | EUR 261 |
Cefoxitin sodium salt |
|||
GA4412-5G | Glentham Life Sciences | 5 g | EUR 351.6 |
Cefazolin sodium salt |
|||
GA4751-1 | Glentham Life Sciences | 1 | EUR 55.4 |
Cefazolin sodium salt |
|||
GA4751-1G | Glentham Life Sciences | 1 g | EUR 103.2 |
Cefazolin sodium salt |
|||
GA4751-5 | Glentham Life Sciences | 5 | EUR 142.4 |
Cefazolin sodium salt |
|||
GA4751-5G | Glentham Life Sciences | 5 g | EUR 208.8 |
Cefapirin sodium salt |
|||
GP5306-1 | Glentham Life Sciences | 1 | EUR 126.5 |
Cefapirin sodium salt |
|||
GP5306-1G | Glentham Life Sciences | 1 g | EUR 189.6 |
Cefapirin sodium salt |
|||
GP5306-250 | Glentham Life Sciences | 250 | EUR 55.4 |
Cefapirin sodium salt |
|||
GP5306-250MG | Glentham Life Sciences | 250 mg | EUR 103.2 |
Ceftiofur sodium salt |
|||
GA9758-1 | Glentham Life Sciences | 1 | EUR 67.9 |
Ceftiofur sodium salt |
|||
GA9758-1G | Glentham Life Sciences | 1 g | EUR 132 |
Cefotaxime Sodium Salt |
|||
20-abx082178 | Abbexa |
|
|
Cefotaxime Sodium Salt |
|||
40310008-1 | Glycomatrix | 5 g | EUR 89.68 |
While avoiding employing traditional and compartmentalized learning approaches, this student-centered guided lesson frames the systemic nature of the microbiological and biochemical processes underlying the decomposition of organic matter in a context of the real world. Anemia is a risk factor for negative results, which can be aggravated by unnecessary phlebotomies. In blood culture tests, up to 30 ml of blood can be removed by sample, although most manufacturers recommend blood volumes of 10 ml or less. After evaluating the volume of filling blood culture bottles in our institution, we investigated the question of whether an educational intervention could optimize the volume of blood culture bottles without negatively affecting microbiology tests.